Entry Point Capital, LLC Insmed Inc Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
A detailed history of Entry Point Capital, LLC transactions in Insmed Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 1,206 shares of INSM stock, worth $89,762. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,206Holding current value
$89,762% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding INSM
# of Institutions
351Shares Held
140MCall Options Held
2.25MPut Options Held
3.11M-
Vanguard Group Inc Valley Forge, PA14.5MShares$1.08 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$878 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$802 Million0.04% of portfolio
-
State Street Corp Boston, MA5.91MShares$440 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.78MShares$356 Million4.29% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.1B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...